PC
GBT

Polar Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Polar Capital’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$19.3M Buy
350,000
+175,000
+100% +$11.1M 0.14% 135
2020
Q2 		$11M Buy
+175,000
New +$12M 0.1% 167
2020
Q1 		– Sell
-75,000
Closed -$5.96M – 323
2019
Q4 		$5.96M Buy
+75,000
New +$4.44M 0.05% 227

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Polar Capital's GBT Position: Q3 2020 in Review

Polar Capital increased its Global Blood Therapeutics, Inc. (GBT) stake by 100% in Q3 2020, buying an estimated $11.1M and bringing the position to 350,000 shares worth $19.3M. The position accounts for 0.14% of the portfolio, ranked #135.

Polar Capital first reported a position in GBT in Q4 2019 and has held it in 3 quarters since. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

  • Polar Capital held 350,000 shares of Global Blood Therapeutics, Inc. worth $19.3M as of Q3 2020.
  • Polar Capital bought 175,000 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $11.1M.
  • Global Blood Therapeutics, Inc. made up 0.14% of Polar Capital's portfolio in Q3 2020, its #135 holding.
  • Polar Capital first reported a position in Global Blood Therapeutics, Inc. in Q4 2019 and has held it in 3 quarters since.
  • 229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.